Improvement in symptoms after H2-receptor antagonist-based therapy for eradication of H pylori infection

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 28

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

336

HTML

1668

Figures (1-2)

195

Tables (1-4)

165

Sum=2364

Jul 28, 2007 (publication date) through Sep 22, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

H Pylori

World J Gastroenterol. Jul 28, 2007; 13(28): 3836-3840
Published online Jul 28, 2007. doi: 10.3748/wjg.v13.i28.3836

Figure 1 Change in symptoms after 1 wk of eradication therapy (comparison of drugs).

Figure 2 Change in symptoms after 1 wk of eradication therapy (success or failure of eradication).

Citation: Hagiwara T, Kato M, Anbo T, Imamura A, Suga T, Uchida T, Fujinaga A, Nakagawa M, Nakagawa S, Shimizu Y, Yamamoto J, Takeda H, Asaka M. Improvement in symptoms after H₂-receptor antagonist-based therapy for eradication of H pylori infection. World J Gastroenterol 2007; 13(28): 3836-3840
URL: https://www.wjgnet.com/1007-9327/full/v13/i28/3836.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i28.3836